Medtronic’s Rist Radial Artery Access Devices Approved in Europe

September 28, 2021—Medtronic announced it has received European CE Mark approval for its radial artery access portfolio, which includes the Rist 079 radial access guide catheter and Rist radial access selective catheter. The devices are available in the United Kingdom, Italy, Spain, Germany, and France.

According to the company, the Rist 079 radial access guide catheter is specifically designed for accessing the neurovasculature through the radial artery versus access through the transfemoral artery. It is indicated for the introduction of interventional devices into the peripheral, coronary, and neuro vasculature. The device received FDA 510(k) clearance and has been used at limited sites in the United States.

The Rist radial access selective catheter is indicated for the introduction of interventional devices into the peripheral, coronary, and neuro vasculature. Additionally, the selective catheter can be used to facilitate introduction of diagnostic agents in the neuro vasculature. It is not intended to facilitate introduction of diagnostic agents in coronary or peripheral arteries.

“With excellent navigability, this first-of-its-kind device will allow clinicians to reach distal locations while still achieving excellent stability to the system,” commented Alejandro Tomasello, MD, in Medtronic’s press release. Dr. Tomasello, who is head of the interventional neuroradiology unit at Vall d’Hebron Hospital in Barcelona, Spain, continued, “The radial artery-access portfolio works well in tandem with Phenom Plus, Phenom 021 microcatheter for stent deployment or Phenom 027 microcatheter for flow diverter deployment, which is a fantastic set up for Pipeline Vantage embolization device with Shield technology treatments.”